The event brought together over 3,000 delegates, including producers, veterinarians, scientists and other players in the supply chain from every continent.
From its stand, HIPRA was able to interact with all of them, demonstrating its ICTHIOVAC® range of inactivated vaccines, indicated for gilthead sea bream, sea bass, trout and turbot.
During the event, HIPRA presented the excellent results obtained in the trial with ICTHIOVAC VR/PD® against Listonella anguillarum in sea bass under adverse conditions of low temperature and a short post-vaccination period.
HIPRA upholds and strengthens its commitment to the prevention of diseases in aquaculture.
